leisure time -WSS

leisure time

author：entertainment 2025-10-04 04:00:48 - browse：8

A medical device to treat below-the-knee chronic limb-threatening ischemia, Esprit BTK resorbable scaffold, is shown consisted of pieces of geometric shapes that lined up into a pipe on a blue background — health tech coverage from STAT — Cardiovascular doctors are optimistic about Abbott’s new below-knee stent that disappears into the blood vessel’s walls over the course of three years. Courtesy Abbott

An Abbott device that failed in heart disease patients is getting a new life in patients with severe vascular disease.

The device is a below-knee stent that widens clogged blood vessels, and then vanishes into the vessel’s walls over the course of three years. It also delivers a drug that prevents scar tissue from forming — a common risk factor with traditional metal stents that further narrow the vessel.

Abbott’s first dissolvable stent, for coronary artery disease, received Food and Drug Administration approval in 2016. But the company voluntarily pulled the product from the market just over a year later due to “low commercial uptake.” The device also received mixed results in clinical trials.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： The painfully weak evidence on taking collagen to treat arthritis

WSS

Prime Medicine, Myeloid Therapeutics clash over genome

Medicare drug price negotiation hasn't dried up venture capital

Germany receives 178 compensation applications from gay servicepeople over discrimination

Can sheer will power keep patients alive in their dying hours?

Virtual care provider acquires bankrupt Pear's prescription apps

Biden praises World Series champion Astros for impact off the field during White House celebration

Wikipedia

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

focus

Heart attack and stroke risk calculators need revising

‘The Bear’ and hospitality in hospitals

Psychedelics group wrestles with new pharma identity

Readout Newsletter: The latest on Moderna, Apellis, and Merck

Alkermes shareholders re

An Ebola outbreak presents a new mystery involving children

The cancer drug shortage isn’t new — and neither are the solutions

Why health care costs have stayed mostly flat since 2010

Dobbs anniversary: the lost opportunity of abortion as health care

‘The Bear’ and hospitality in hospitals

knowledge

An Ebola outbreak presents a new mystery involving children

Medicare drug price negotiation hasn't dried up venture capital

Keeping primary care docs in field isn't impossible, says AAFP CEO

Boston man files lawsuit seeking to bankrupt white supremacist group he says assaulted him

Former Georgia lieutenant governor says he received grand jury subpoena

Drinking less cuts risk of oral cavity, esophageal cancer: Report

knowledge

leisure time

leisure time

entertainment